Reference health

<i><scp>BRCA1</scp></i> and <i><scp>BRCA2</scp></i> mutations and the risk for colorectal cancer

https://doi.org/10.1111/cge.12497
CiteStamped reference-health badge
50/50 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 50 checked references that resolve
resolves10.1016/0092-8674(93)90546-3
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
resolves10.1016/S1097-2765(00)80202-6
Brca1 Controls Homology-Directed DNA Repair
resolves10.1016/S1097-2765(01)00174-5
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
resolves10.1038/nrc1431
BRCA1 and BRCA2: 1994 and beyond
resolves10.1086/375033
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
resolves10.1093/jnci/94.18.1358
Cancer Incidence in BRCA1 Mutation Carriers
resolves10.1093/jnci/91.15.1310
Cancer Risks in BRCA2 Mutation Carriers
resolves10.1007/BF02236700
Colorectal cancer in hereditary breast cancer kindreds
resolves10.6004/jnccn.2010.0003
Colorectal Cancer Screening
resolves10.1056/NEJM199312303292701
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
resolves10.3322/caac.21220
Colorectal cancer statistics, 2014
resolves10.3322/CA.2007.0018
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
resolves10.1002/bjs.5084
Prevalence of family history of colorectal cancer in the general population
resolves10.1111/j.1572-0241.2001.04677.x
A systematic review and meta-analysis of familial colorectal cancer risk
resolves10.1007/s10689-005-0657-x
Frequency of Familial Colon Cancer and Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in a Large Population Database
resolves10.1111/cge.12359
Panel‐based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory
resolves10.1038/gim.2014.40
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
resolves10.1093/jnci/94.18.1365
Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program
resolves10.1016/S0140-6736(94)91578-4
Risks of cancer in BRCA1-mutation carriers
resolves10.1136/jmg.2006.048173
Cancer risks in carriers of the <i>BRCA1/2</i> Ashkenazi founder mutations
resolves10.1038/bjc.2013.741
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
resolves10.1056/NEJM199705153362001
The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews
resolves10.1054/bjoc.2000.1598
The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
resolves10.1086/318787
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
resolves10.1136/jmg.39.7.457
The effect of a single <i>BRCA2</i> mutation on cancer in Iceland
resolves10.1093/jnci/djh006
Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer
resolves10.1007/s10689-010-9378-x
BRCA1 mutations and colorectal cancer in Poland
resolves10.1093/jnci/djh008
BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer
resolves10.2215/CJN.00080106
Cohort Studies
resolves10.1093/jnci/djj465
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
resolves10.1016/S1052-5157(18)30292-7
Growth Rate of Colon Polyps and Cancer
resolves10.1007/s00292-012-1640-6
The natural history of colorectal adenomas and early cancer
resolves10.7326/0003-4819-123-12-199512150-00002
Prevention of Colorectal Cancer by Flexible Endoscopy and Polypectomy: A Case-Control Study of 32 702 Veterans
resolves10.1001/jama.295.20.2366
Risk of Developing Colorectal Cancer Following a Negative Colonoscopy Examination
resolves10.1111/j.1572-0241.2008.01875.x
Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update
resolves10.1016/S0140-6736(10)62110-1
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
resolves10.1056/NEJMoa021735
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
resolves10.1016/S0140-6736(11)61720-0
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
resolves10.1016/S0140-6736(10)61543-7
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
resolves10.1016/S0140-6736(11)61049-0
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
resolves10.1016/j.amjcard.2005.01.049
Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
resolves10.1001/jama.280.22.1930
Aspirin and Risk of Hemorrhagic Stroke
resolves10.1093/jnci/djn485
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
resolves10.7326/0003-4819-146-5-200703060-00008
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
resolves10.1200/JCO.2012.47.8313
Tamoxifen and Risk of Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
resolves10.1016/S1470-2045(11)70030-4
Preventive therapy for breast cancer: a consensus statement
resolves10.1016/j.jsbmb.2005.06.018
Vitamin D and prevention of colorectal cancer
resolves10.1016/j.annepidem.2009.03.021
Vitamin D for Cancer Prevention: Global Perspective
resolves10.1097/00001648-199403000-00003
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
resolves10.1007/s10552-006-0033-7
Aspirin and cancer risk: an updated quantitative review to 2005
The 4 references without a DOI — listed, not checked
no DOI — not checkedMutator phenotype may be required for multistage carcinogenesis
no DOI — not checkedFamilial breast cancer and the association with colonic carcinoma
no DOI — not checkedAre women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
no DOI — not checkedIncidence of and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/cge.12497"><img src="https://citestamp.com/citestamped/10.1111/cge.12497/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/cge.12497/badge.svg)](https://citestamp.com/citestamped/10.1111/cge.12497)